People with multiple sclerosis might soon have a new option for controlling their disease with pills instead of shots. Two studies in the Sept. 20 New England Journal of Medicine demonstrate that a variation on a drug used against psoriasis for years in Germany holds off MS relapses and has minimal side effects.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.